X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (41) 41
female (34) 34
middle aged (25) 25
oncology (23) 23
adult (22) 22
aged (20) 20
male (19) 19
cancer (18) 18
life sciences (18) 18
breast neoplasms - genetics (14) 14
mutation (14) 14
research (14) 14
care and treatment (13) 13
genetic predisposition to disease (13) 13
heterozygote (13) 13
risk factors (13) 13
breast cancer (12) 12
tumors (12) 12
alleles (11) 11
retrospective studies (11) 11
treatment outcome (11) 11
chemotherapy (10) 10
disease-free survival (10) 10
health aspects (10) 10
mortality (10) 10
polymorphism, single nucleotide (10) 10
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
patients (9) 9
skin and connective tissue diseases (9) 9
aged, 80 and over (8) 8
brca1 protein (8) 8
brca1 protein - genetics (8) 8
cancer therapies (8) 8
diagnosis (8) 8
genes, brca2 (8) 8
genome-wide association (8) 8
medicine (8) 8
survival (8) 8
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (7) 7
acquired immune deficiency syndrome--aids (7) 7
drug therapy (7) 7
genes, brca1 (7) 7
genetics & heredity (7) 7
histoplasmosis (7) 7
hiv (7) 7
human immunodeficiency virus--hiv (7) 7
medical prognosis (7) 7
population (7) 7
prognosis (7) 7
santé publique et épidémiologie (7) 7
brca2 protein (6) 6
brca2 protein - genetics (6) 6
breast neoplasms - pathology (6) 6
cancer and oncology (6) 6
cancer och onkologi (6) 6
clinical medicine (6) 6
disease (6) 6
endocrine system diseases (6) 6
esophageal cancer (6) 6
genetic aspects (6) 6
hematology, oncology and palliative medicine (6) 6
infections (6) 6
infectious diseases (6) 6
klinisk medicin (6) 6
laboratories (6) 6
metastasis (6) 6
ovarian-cancer (6) 6
parasitology (6) 6
tropical medicine (6) 6
tuberculosis (6) 6
young adult (6) 6
aids (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
biochemistry & molecular biology (5) 5
epidemiology (5) 5
estrogen-receptor (5) 5
france (5) 5
gene mutations (5) 5
genetics (5) 5
genotype (5) 5
neoplasm staging (5) 5
research article (5) 5
risk (5) 5
studies (5) 5
surgery (5) 5
susceptibility (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (4) 4
acquired immune deficiency syndrome (4) 4
antiretroviral drugs (4) 4
arctic medicine. tropical medicine (4) 4
article (4) 4
association studies (4) 4
association studies articles (4) 4
carcinoma (4) 4
chemoradiotherapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 942 - 949
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 632 - 641
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 11/2017, Volume 17, Issue 11, pp. e334 - e343
Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS. Systemic infections are mainly with (pneumocystosis),... 
PENICILLIUM-MARNEFFEI INFECTION | CLINICAL-PRACTICE GUIDELINES | INSTITUTES-OF-HEALTH | INFECTIOUS DISEASES | POLYMERASE-CHAIN-REACTION | RECONSTITUTION INFLAMMATORY SYNDROME | HIV MEDICINE ASSOCIATION | NATURAL ANIMAL HOST | PNEUMOCYSTIS-CARINII PNEUMONIA | CRYPTOCOCCAL MENINGITIS | CHI MINH CITY | Mycoses - epidemiology | Fungi - classification | Humans | AIDS-Related Opportunistic Infections - drug therapy | Fungi - isolation & purification | Mycoses - microbiology | AIDS-Related Opportunistic Infections - diagnosis | AIDS-Related Opportunistic Infections - microbiology | Antifungal Agents - therapeutic use | Incidence | HIV Infections - immunology | Point-of-Care Systems | AIDS-Related Opportunistic Infections - epidemiology | Diagnostic Tests, Routine - methods | HIV Infections - complications | Mycoses - drug therapy | Mycoses - diagnosis | HIV testing | Mycoses | HIV patients | Health aspects | HIV infection | Antiviral agents | Medical colleges | Pneumonia | Bacterial pneumonia | HIV (Viruses) | Highly active antiretroviral therapy | Amphotericin B | Flucytosine | Antiparasitic agents | Drugs | Antiretroviral drugs | Histoplasmosis | Fungicides | Penicillium | Cryptococcosis | Infections | Drug resistance | Epidemiology | Disease control | Patients | CD4 antigen | Fungi | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Fungal diseases | Pneumocystosis | Human immunodeficiency virus--HIV | Cryptococcus | Diagnostic systems | Life Sciences | Santé publique et épidémiologie
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 305 - 314
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 395 - 405
Journal Article
by Antoniou, Antonis C and Kartsonaki, Christiana and Sinilnikova, Olga M and Soucy, Penny and McGuffog, Lesley and Healey, Sue and Lee, Anew and Peterlongo, Paolo and Manoukian, Siranoush and Peissel, Bernard and Zaffaroni, Daniela and Cattaneo, Elisa and Barile, Monica and Pensotti, Valeria and Pasini, Barbara and Dolcetti, Riccardo and Giannini, Giuseppe and Putignano, Anna Laura and Varesco, Liliana and Radice, Paolo and Mai, Phuong L and Greene, Mark H and Anulis, Irene L and Glendon, Gord and Ozcelik, Hilmi and Thomassen, Mads and Gerdes, Anne-Marie and Kruse, Torben A and Birk Jensen, Uffe and Crüger, Dorthe G and Caligo, Maria A and Laitman, Yael and Milgrom, Roni and Kaufman, Bella and Paluch-Shimon, Shani and Friedman, Eitan and Loman, Niklas and Harbst, Katja and Lindblom, Annika and Arver, Brita and Ehrencrona, Hans and Melin, Beatrice and Nathanson, Katherine L and Domchek, Susan M and Rebbeck, Timothy and Jakubowska, Ania and Lubinski, Jan and Gronwald, Jacek and Huzarski, Tomasz and Byrski, Tomasz and Cybulski, Cezary and Gorski, Bohdan and Osorio, Ana and Ramón Y Cajal, Teresa and Fostira, Florentia and Anés, Raquel and Benitez, Javier and Hamann, Ute and Hogervorst, Frans B and Rookus, Matti A and Hooning, Maartje J and Nelen, Marcel R and van der Luijt, Rob B and van Os, Theo A. M and van Asperen, Christi J and Devilee, Peter and Meijers-Heijboer, Hanne E. J and Gómez Garcia, Encarna B and Peock, Susan and Cook, Margaret and Frost, Debra and Platte, Radka and Leyland, Jean and Evans, D. Gareth and Lalloo, Fiona and Eeles, Ros and Izatt, Louise and Adlard, Julian and Davidson, Rosemarie and Eccles, Diana and Ong, Kai-Ren and Cook, Jackie and Douglas, Fiona and Paterson, Joan and Kennedy, M. John and Miedzybrodzka, Zosia and Godwin, Anew and Stoppa-Lyonnet, Dominique and Buecher, Bruno and Belotti, Muriel and Tirapo, Carole and Mazoyer, Sylvie and Barjhoux, Laure and Lasset, Christine and Leroux, Dominique and Faivre, Laurence and Bronner, Myriam and Prieur, Fabienne and Nogues, Catherine and Rouleau, Etienne and ... and kConFab Investigators and EMBRACE and CEMO Study Collaborators and CIMBA and HEBON and Breast Canc Family Registry and SWE-BRCA and Breast Cancer Family Registry and kConFab investigators and on behalf of CIMBA and Medicinska fakulteten and Institutionen för strålningsvetenskaper and Onkologi and Umeå universitet
Human molecular genetics, ISSN 0964-6906, 2011, Volume 20, Issue 16, pp. 3304 - 3321
Journal Article